Dr. Premanand Sundivakkam, Ph.D., MBA., BCMAS is a seasoned board-certified medical affairs professional, recognized for his scientific acumen and medical voice within the pharmaceutical and medical devices industries. His specializations in oncology, hematology, and rare diseases demonstrate his commitment to advancing medical knowledge across diverse fields.
Dr. Sundivakkam’s academic credentials, including a PhD from The Tamil Nadu Dr. MGR Medical University and an MBA from the University of Illinois at Urbana Champaign, have equipped him with a unique blend of scientific expertise and business acumen.
As a prolific author, Dr. Sundivakkam has contributed to 23 highly cited peer-reviewed journals and served on the editorial board for several internationally acclaimed journals, such as the American Journal of Physiology, PLoS One, and Molecular Pharmacology. His extensive publications underscore his dedication to sharing knowledge and advancing the field of medical affairs.
In his leadership role at the Medical Affairs Professional Society (MAPS), Dr. Sundivakkam oversees the Midwest Territory and serves in the Working Group on Medical Insights. His leadership extends beyond organizational boundaries, fostering cross-industry partnerships and driving innovation in the field. This is further evidenced by his successful leadership of the 2023 and 2024 Medical Affairs Technology and Innovation Summits.
Dr. Sundivakkam’s professional contributions have been recognized with several awards, including the 2023 Professional Contribution Award by MAPS and the “Top 100 Under 50” award by DiversityMBA. During his academic days, he was an American Heart Fellow, a testament to his longstanding commitment to medical research.